SAN DIEGO--(BUSINESS WIRE)--AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced the appointment of three recognized experts in antibody therapeutics, business development, and project and alliance management to its senior management team as part of its strategic growth plan for 2009 and beyond.
